L2 is a temperate mycoplasma virus containing 11.8 kilobase pairs of negatively superhelical doublestranded DNA. We observed L2 DNA with less superhelicity in novobiocin-treated cells than that in untreated cells. However, although no change in viral DNA superhelicity could be found in novobiocintreated novobiocin-resistant cells, L2 production decreased in these novobiocin-treated cells.
(4).
The L2 infection cycle allows studies of the role of DNA superhelicity in DNA replication and maturation of an enveloped virus. Hence, the effect of novobiocin on intracellular L2 DNA replication was investigated. Novobiocin irhibits bacterial DNA replication; transcription is inhibited to a lesser extent (15) . The effect is due to novobiocin inhibition of DNA gyrase (6) , an enzyme that catalyzes the ATP-dependent introduction of negative superhelical turns into circular double-stranded DNA. Gyrase is needed for processes (involving cell, plasmid, and phage DNAs) that require negatively superhelical DNA, such as DNA replication, transcription, repair, and recombination (reviewed in reference 1).
We report here studies using novobiocin to investigate the role of DNA superhelicity in mycoplasma virus L2 DNA replication and maturation. The effect on L2 growth of 2-h treatments with different novobiocin concentrations 2.5 h postinfection is shown in Fig. 1 . Virus yield decreased logarithmically with increasing novobiocin concentrations up to 5 p.g/ml. At the maximum concentration used in these studies (10 pLg of novobiocin per ml) L2 yield was about 5% that of untreated infected cells.
The effect of novobiocin on L2 growth was examined during the viral one-step growth cycle (Fig. 2) (Fig. 3b ), but L2 inhibition was not as extensive as in JAl cells (Fig. 3a) . To correct for differences in L2 yield between JAl and JAl Novr cells, the yield at 5 h postinfection in novobiocin-treated cells must be compared to that for untreated cells (Fig. 3) (Fig. 4) . Under these conditions, L2 RFI molecules (circular superhelical double-stranded DNA) were in fraction 17 and replicative-form II DNA (RFII) molecules (a relaxed form of RFI) were in fraction 10. Material sedimenting faster than fraction 20 was cellular DNA.
The amount of DNA synthesized at each novobiocin concentration was measured as the total counts per minute in each gradient and is given in the legend to Fig. 4 . The decrease in DNA synthesis with increasing novobiocin concentrations followed a logarithmic relationship, similar to that between virus yield and novobiocin concentration (Fig.  1) . Hence, novobiocin inhibition of virus production reflects inhibition of DNA synthesis.
The sucrose gradients (Fig. 4) showed that at novobiocin concentrations up to 1 ,ug/ml, both viral and cellular DNA replication are inhibited to the same extent. At 2.5 ,g of A logphase culture of JAl cells was infected with L2 at a multiplicity of infection of 5. Growth, media, and assay of L2 as PFU were as described previously (11, 13 Fig. 4 , as a function of novobiocin concentration. novobiocin per ml, the data were obscured by a spread of the cellular DNA peak.
To investigate the degree of superhelicity of L2 DNA synthesized in the presence of novobiocin, infected cell lysates were analyzed by CsCl-ethidium bromide equilibrium centrifugation. This analysis of purified L2 [3H]DNA produced two peaks (Fig. 5a) . The less dense peak in fractions 16 and 17 should be linear and nicked circular DNA molecules and the more dense peak in fractions 23 and 24 should be circular superhelical DNA molecules, since covalently closed molecules (due to topological constraints) bind less ethidium than the corresponding linear and nicked circular forms and, hence, have a greater density. In agreement with this, JAl cell DNA, which is sheared to linear molecules in lysates, formed a band at about fraction 16 (Fig.  5c ). (Both L2 viral DNA and JAl cellular DNA are 32% guanine plus cytosine [5] .)
DNA from untreated infected JAl cells formed two peaks, one at fractions 16 and 17 and one at fractions 23 and 24 (Fig.  5b) . However, DNA from infected JAl cells treated with 2.5 ,ug of novobiocin per ml contained these two peaks plus an additional, more dense peak at fraction 27 (Fig. Sd) Fig. 1 . At 1.5 h postinfection, the culture was divided into four parts, each 5-ml sample receiving either 0 (0), 0.5 (0), 1.0 (A), or 2.5 (O) ,ug of novobiocin per ml. Each also received 30 ,uCi of [3H]deoxythymidine per ml and was incubated for a further 4 h. At 5.5 h postinfection, all samples were lysed with 0.4% Sarkosyl NL97 and analyzed by sucrose gradient centrifugation. The lysis and S to 20% (wt/vol) sucrose gradient centrifugation conditions have been described previously (2), as have the procedures for measurement of acidprecipitable radioactivity (7). For each gradient, the percent acidprecipitable counts per minute in each fraction is plotted. The total in each gradient was 739,578 cpm for no novobiocin, 605,146 cpm for 0.5 F±g of novobiocin per ml, 323,192 cpm for 1.0 ,ug of novobiocin per ml, and 105,678 cpm for 2.5 F±g of novobiocin per ml. The peak in fraction 17 is L2 RFI DNA, and the material in fraction 10 is L2 RFII DNA, as determined from a parallel gradient containing purified L2 [3H]DNA. Material sedimenting faster than fraction 20 is cellular DNA. The data scatter in fractions 27 and 28 is due to mixing with the cushion during unloading of the gradients. ml contained material only in two peaks, in fractions 16 and 17 and fractions 23 and 24 (Fig. 5e ). Therefore, a reduction in negative superhelicity in intracellular L2 DNA due to novobiocin treatment was observed in JAl cells, but not in JAl Novr cells.
These studies indicate that mycoplasmas have a novobiocin-sensitive DNA gyrase activity which is involved in L2 viral DNA replication. In JAl cells, but not in JAl Novr cells, L2 DNA with less negative superhelicity is synthesized after novobiocin addition (Fig. 5) . However, novobiocin does cause some inhibition in L2 production in JAl Novr cells (Fig. 3b) , although L2 DNA synthesized in novobiocintreated JAl Novr cells appears to have normal negative superhelicity (Fig. Se) . This suggests that L2 replication also involves another novobiocin-sensitive process in addition to DNA supercoiling. A similar situation has been reported for adenovirus replication, which seems to involve two novobiocin-sensitive steps, one being DNA gyrase-dependent DNA synthesis and the other being DNA maturation or encapsidation or both (3). Since the L2 chromosome is packaged in the virion as a superhelical molecule (11) , L2 assembly and budding may also involve a novobiocin-sensitive process. However, we cannot exclude the possibility that novobiocin inhibition of L2 virus in JAl Novr cells is due to a small decrease in superhelicity which has not been resolved in these studies or to decreased transcription of viral DNA under these conditions. 
